Literature DB >> 20560031

General overview of the Sixth International Symposium on Stem Cell Therapy and Cardiovascular Innovations.

Ma Eugenia Vázquez-Alvarez1, Ricardo Sanz-Ruiz, Enrique Gutiérrez, Adolfo Villa, Ma Eugenia Fernández, Sandra Vázquez, Ma José Lorenzo, Lucía Fernández, Isaac Pascual, Pedro L Sánchez, Francisco Fernández-Avilés.   

Abstract

Being one of the main stem cell therapy meetings of the year, the Sixth International Symposium on Stem Cell Therapy and Cardiovascular Innovations was held on April 23rd-24th, 2009, at the Auditorium of the High Council of Scientific Research of Spain (CSIC) in Madrid. Gathering the most prestigious basic researchers and clinical experts in the field of cardiovascular regenerative medicine, the aim of the meeting was to discuss the available evidence and the recent contributions from preclinical investigators, cardiologists, and cardiac surgeons in a participative translational fashion. The role of young "clinician scientists" was reinforced with a special poster session and three awards. The main conclusions of the symposium were (1) that standardization, larger clinical trials, and true translational research are needed, and (2) that new-allogeneic-stem cell products, biotechnological devices, and cell-based bioartificial organs are potentially exciting options for the future.

Mesh:

Year:  2009        PMID: 20560031     DOI: 10.1007/s12265-009-9156-z

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  41 in total

1.  Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.

Authors:  Gerd P Meyer; Kai C Wollert; Joachim Lotz; Jan Steffens; Peter Lippolt; Stephanie Fichtner; Hartmut Hecker; Arnd Schaefer; Lubomir Arseniev; Bernd Hertenstein; Arnold Ganser; Helmut Drexler
Journal:  Circulation       Date:  2006-03-06       Impact factor: 29.690

2.  Use of arginine-glycine-aspartic acid adhesion peptides coupled with a new collagen scaffold to engineer a myocardium-like tissue graft.

Authors:  O Schussler; C Coirault; M Louis-Tisserand; W Al-Chare; P Oliviero; C Menard; R Michelot; P Bochet; D R Salomon; J C Chachques; A Carpentier; Y Lecarpentier
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2009-03

3.  Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells.

Authors:  Timothy J Nelson; Almudena Martinez-Fernandez; Satsuki Yamada; Carmen Perez-Terzic; Yasuhiro Ikeda; Andre Terzic
Journal:  Circulation       Date:  2009-07-20       Impact factor: 29.690

4.  Heart transplantation: the end of the beginning.

Authors:  M Yacoub
Journal:  Am J Transplant       Date:  2008-09       Impact factor: 8.086

Review 5.  Stem-cell-based therapy and lessons from the heart.

Authors:  Robert Passier; Linda W van Laake; Christine L Mummery
Journal:  Nature       Date:  2008-05-15       Impact factor: 49.962

6.  Effects of cardiac patches engineered with bone marrow-derived mononuclear cells and PGCL scaffolds in a rat myocardial infarction model.

Authors:  Hainan Piao; Jin-Sook Kwon; Shuguang Piao; Ju-Hee Sohn; Yeong-Shin Lee; Jang-Whan Bae; Kyung-Kuk Hwang; Dong-Woon Kim; Oju Jeon; Byung-Soo Kim; Young-Bae Park; Myeong-Chan Cho
Journal:  Biomaterials       Date:  2006-10-10       Impact factor: 12.479

7.  Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

Authors:  Volker Schächinger; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Hans Hölschermann; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Birgit Assmus; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

8.  Characterization of the expression of MHC proteins in human embryonic stem cells.

Authors:  Micha Drukker; Gil Katz; Achia Urbach; Maya Schuldiner; Gal Markel; Joseph Itskovitz-Eldor; Benjamin Reubinoff; Ofer Mandelboim; Nissim Benvenisty
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-11       Impact factor: 11.205

Review 9.  Toward microRNA-based therapeutics for heart disease: the sense in antisense.

Authors:  Eva van Rooij; William S Marshall; Eric N Olson
Journal:  Circ Res       Date:  2008-10-24       Impact factor: 17.367

10.  Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts.

Authors:  Rutger-Jan Swijnenburg; Sonja Schrepfer; Johannes A Govaert; Feng Cao; Katie Ransohoff; Ahmad Y Sheikh; Munif Haddad; Andrew J Connolly; Mark M Davis; Robert C Robbins; Joseph C Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.